Search research articles
Contact Us
Filters
Showing results (791-800 of 3,474) with videos related to
Page
of 348
Sort By:
Frontiers in Immunology
|
July 6, 2017
CD25 <sup></sup> B-1a Cells Express <i>Aicda</i>
Hiroaki Kaku, Nichol E Holodick, Joseph R Tumang, et al.
Endocrine Journal
|
April 9, 2009
Addition of mitiglinide to pioglitazone monotherapy improves overall glycemic control in Japanese patients with type 2 diabetes: a randomized double blind trial
Kohei Kaku, Shun-ichi Tanaka, Hideki Origasa, et al.
Acta Medica Portuguesa
|
May 1, 1989
[Rheumatic cardiopathy in children. A comparative study in 2 consecutive 9-year periods]
A Macedo, M Primo, S Kaku, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 14, 2014
A novel mechanism of B cell-mediated immune suppression through CD73 expression and adenosine production
Hiroaki Kaku, Kai Fan Cheng, Yousef Al-Abed, et al.
Frontiers in Cardiovascular Medicine
|
January 10, 2018
Anti-inflammatory Nanomedicine for Cardiovascular Disease
Shunsuke Katsuki, Tetsuya Matoba, Jun-Ichiro Koga, et al.
Frontiers in Molecular Neuroscience
|
December 31, 2021
Fas Apoptosis Inhibitory Molecule Blocks and Dissolves Pathological Amyloid-β Species
Hiroaki Kaku, Alexander V Ludlow, Michael F Gutknecht, et al.
Journal of Clinical Medicine
|
March 29, 2023
Nail Apparatus Melanoma: Current Management and Future Perspectives
Takamichi Ito, Hiroki Hashimoto, Yumiko Kaku-Ito, et al.
Cureus
|
August 23, 2021
A Case of Angioimmunoblastic T-cell Lymphoma That Mimics As Autoimmune Diseases and Infections
Kaku Kuroda, Ajay Tambe, Rahila Iftikhar, et al.
Biochemical and Biophysical Research Communications
|
March 9, 2004
Flt3 mutation activates p21WAF1/CIP1 gene expression through the action of STAT5
Shinichiro Takahashi, Hideo Harigae, Mitsuo Kaku, et al.
Diabetes, Obesity & Metabolism
|
December 6, 2021
Long-term safety and efficacy of imeglimin as monotherapy or in combination with existing antidiabetic agents in Japanese patients with type 2 diabetes (TIMES 2): A 52-week, open-label, multicentre phase 3 trial
Julie Dubourg, Pascale Fouqueray, Damien Quinslot, et al.
Page
of 348
Search research articles
Search
Showing results (791-800 of 3,474) with videos related to
Sort By:
Page
of 348
Frontiers in Immunology
|
July 6, 2017
CD25 <sup></sup> B-1a Cells Express <i>Aicda</i>
Hiroaki Kaku, Nichol E Holodick, Joseph R Tumang, et al.
Endocrine Journal
|
April 9, 2009
Addition of mitiglinide to pioglitazone monotherapy improves overall glycemic control in Japanese patients with type 2 diabetes: a randomized double blind trial
Kohei Kaku, Shun-ichi Tanaka, Hideki Origasa, et al.
Acta Medica Portuguesa
|
May 1, 1989
[Rheumatic cardiopathy in children. A comparative study in 2 consecutive 9-year periods]
A Macedo, M Primo, S Kaku, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 14, 2014
A novel mechanism of B cell-mediated immune suppression through CD73 expression and adenosine production
Hiroaki Kaku, Kai Fan Cheng, Yousef Al-Abed, et al.
Frontiers in Cardiovascular Medicine
|
January 10, 2018
Anti-inflammatory Nanomedicine for Cardiovascular Disease
Shunsuke Katsuki, Tetsuya Matoba, Jun-Ichiro Koga, et al.
Frontiers in Molecular Neuroscience
|
December 31, 2021
Fas Apoptosis Inhibitory Molecule Blocks and Dissolves Pathological Amyloid-β Species
Hiroaki Kaku, Alexander V Ludlow, Michael F Gutknecht, et al.
Journal of Clinical Medicine
|
March 29, 2023
Nail Apparatus Melanoma: Current Management and Future Perspectives
Takamichi Ito, Hiroki Hashimoto, Yumiko Kaku-Ito, et al.
Cureus
|
August 23, 2021
A Case of Angioimmunoblastic T-cell Lymphoma That Mimics As Autoimmune Diseases and Infections
Kaku Kuroda, Ajay Tambe, Rahila Iftikhar, et al.
Biochemical and Biophysical Research Communications
|
March 9, 2004
Flt3 mutation activates p21WAF1/CIP1 gene expression through the action of STAT5
Shinichiro Takahashi, Hideo Harigae, Mitsuo Kaku, et al.
Diabetes, Obesity & Metabolism
|
December 6, 2021
Long-term safety and efficacy of imeglimin as monotherapy or in combination with existing antidiabetic agents in Japanese patients with type 2 diabetes (TIMES 2): A 52-week, open-label, multicentre phase 3 trial
Julie Dubourg, Pascale Fouqueray, Damien Quinslot, et al.
Page
of 348